d-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking statements can be
identified by terminology such as "anticipate," "believe," "could," "could
increase the likelihood," "estimate," "expect," "intend," "is planned,"
"may," "should," "will," "will enable," "would be expected," "look
forward," "may provide," "would" or similar terms, variations of such terms
or the negative of those terms. Such forward-looking statements involve
known and unknown risks, uncertainties and other factors including those
risks, uncertainties and factors referred to in the Company's Quarterly
Report on Form 10-K for the year ended December 31, 2007 filed with the
Securities and Exchange Commission under the section "Risk Factors," as
well as other documents that may be filed by CollaGenex from time to time
with the Securities and Exchange Commission as well as related to the
satisfaction of the closing conditions in the merger agreement. As a result
of such risks, uncertainties and factors, the Company's actual results may
differ materially from any future results, performance or achievements
discussed in or implied by the forward-looking statements contained herein.
CollaGenex is providing the information in this press release as of this
date and assumes no obligations to update the information included in this
press release or revise any forward-looking statements, whether as a result
of new information, future events or otherwise.
Restoraderm(R), SansRosa(R) and Oracea(R) are registered trademarks and
IMPACS(TM) is a trademark of CollaGenex Pharmaceuticals, Inc.
Novacort(R) and Alcortin(R) A are trademarks of Primus Pharmaceuticals,
Differin(R), Metrogel(R), Clobex(R), Tri-Luma(R), Cetaphil(R) and
Epiduo(R) are trademarks of Galderma Pharma S.A.
Pliaglis(R) is a trademark of Zars Pharma Inc. and Dysport(R) is a
trademark of Ipsen Ltd.
All other trade names, trademarks or service marks aPage: 1 2 3 4 5 Related medicine news :1
. ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic2
. Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)3
. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals4
. Galderma Associates Itself to Cartiers Womens Initiative Awards to Recognize Female Entrepreneurs From Around the Globe5
. The Pennsylvania Breast Cancer Coalition Announces Event at the University of Pennsylvania Hospital to Celebrate the 2008 Income Tax Check-Off Campaign6
. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated7
. PRA International Announces New Office Opening in Mumbai8
. Cardiums InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems9
. Varian Announces Global Clinical Council to Develop RapidArc(TM) Cancer Treatments10
. Forest Laboratories Announces Resignation of Ivan Gergel, MD11
. National Parkinson Foundation Announces Its New President and CEO